Company Overview
About Immunovant, Inc.
Immunovant, Inc. is a biopharmaceutical company based in the United States. The company is focused on developing treatments for autoimmune diseases, with a patient-centered approach to address the complex and variable needs of individuals affected by these conditions. Immunovant's pipeline includes ongoing clinical trials, and the company is committed to advancing new therapies to improve the lives of people with autoimmune diseases.
Frequently Asked Questions about Immunovant, Inc.
Technologies Used
Key Decision Makers
Farah Ali Vice President Clinical Development
Steve Tisi Senior Director, Clinical Operations
Aileen Ilaria Vice President Clinical Operations
Joanne Dourado Sr Director, Clinical Operations-Site Relationship Mgmt
Georgene Nathan Clinical Trial Manager
Sagar Bhatt Senior Clinical Trial Associate
Achint Chani Senior Clinical Trial Manager
Sarah Mayo Clinical Trial Manager
Donella Colville, PMP Senior Clinical Trial Manager
Jayme Hentig, PhD, MBA Director, Clinical Research Scientist
Marisa DeLay Clinical Trial Manager
Hannah Petrek, PhD Director, Clinical Research Scientist